ArticleNature communications2026
Direct imaging-based gradient metasurface sensor enabling spectrometer-free ultrasensitive biomolecule detection.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spectral sensing at a glance.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Biosensors play a crucial role in modern diagnostics, where simple, portable systems can enable rapid on-site testing. Here, we introduce a direct imaging-based biosensor capable of reconstructing spectral shifts from transmission images without the need for a spectrometer. By introducing a continuous geometry gradient in a dielectric metasurface, we spatially encode distinct resonance wavelengths across the device, enabling quasi-continuous spectral readout from a single camera image. Our platform achieves a high-quality factor and fine 0.1 nm spectral step size across a broad 30 nm spectral window within a 300 µm footprint, without spectroscopic instrumentation. This direct imaging-based approach exhibits high sensitivity with a figure of merit of 67.2 per refractive index unit and enables label-free detection of both proteins and DNA, reaching a limit of detection down to 388 picomolar. This spectrometer-free biosensor presents a compact sensing platform with a clear pathway toward a potentially more cost-effective implementation than conventional optical refractometric sensors, enabled by a simplified optical architecture facilitating molecular testing beyond specialized laboratory settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.